CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

ORCL Price Prediction: UBS backs Oracle as tokenized stock tests support after heavy selling

Blockchain.News logo

Published on

Add as a preferred source on Google
ORCL Price Prediction: UBS backs Oracle as tokenized stock tests support after heavy selling

Oracle Tokenized Stock (ORCL) is trading at $113.74, down 1.80% on the day, with price still below its short- and medium-term moving averages. On Binance Futures, positioning is net-long but taker ...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

Oracle Tokenized Stock is quoted at $113.74, after a 1.80% 24-hour decline inside a range of $116.97 to $113.32. That keeps the Binance instrument below its 7-day SMA at $117.90, its 20-day SMA at $125.35, and its 50-day SMA at $133.24, so the short-term tape remains corrective rather than trend-confirming.

The broader news flow around the underlying Oracle equity has been mixed but not broken. UBS kept a Buy rating and an unchanged $250 target on November 4, arguing that fears around AI demand and supply are overstated, while Stephens upgraded Oracle to Overweight and lifted its target to $213 on November 2. MarketBeat also cited an average analyst target of $249.27 from 47 firms, although those targets apply to the equity, not the Binance tokenized instrument.

The chart structure is leaning lower. ORCL’s RSI of 36.13 sits in neutral territory but is close to oversold, while MACD is negative at -5.3041 and the stochastic readings are weak, with %K at 11.27 and %D at 9.02. Price is also sitting near the lower Bollinger Band at $110.61, with %B at 0.1058, which suggests the market is pressing into the lower end of its recent volatility envelope.


Source link
Related Topics:Web3 & Blockchain

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.